VCEL Vericel
$40.05 -2.48%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.48%
YTD
+21.00%
P/E
83.49
P/B
5.14
ROE
6.9%
Div yield
—
Beta
0.79
Market cap
$2.0B
RSI (14)
48
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$41.38
Close
$40.05
VWAP (n/a)
—
Day high
$41.45
Day low
$39.65
Volume
669K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Vericel (VCEL) Stock Looks Fully Priced After A 31% Gain
Yahoo Finance · Sep 26
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
Yahoo Finance · Sep 8
Vericel Q2 Earnings Call Highlights
Yahoo Finance · Jul 30
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
Yahoo Finance · Jul 16
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Yahoo Finance · May 30
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance · Aug 13
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View → 8-K May 18, 2026 View → 10-Q May 7, 2026 View → 8-K May 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VCEL. Try it in the Lab to size a position and see the risk.